Jaguar HealthJAGX

13F holders, Q1 2026 (March 31)
11holders
3new positions
3sold out
$0.37avg. 13F price*

At the end of Q1 2026, 11 institutions reported holding Jaguar Health Inc. (JAGX) in their 13F filings, unchanged from Q4 2025. 3 opened new positions and 3 sold out. The largest holders were UBS Group AG ($42K), Geode Capital Management, LLC ($41K) and HRT Financial LP ($5K).

Company
Jaguar Health Inc.
CUSIP
47010C888
Latest filing quarter
Q1 2026

History

Number of 13F holders

051015 Q1 2025: 8Q1 2025Q2 2025: 8Q2 2025Q3 2025: 9Q3 2025Q4 2025: 11Q4 2025Q1 2026: 11Q1 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions3$10K
Exits3$28K

All 13F filers, Q4 2025 → Q1 2026: 222,881 shares bought and 31,602 shares sold, net +191,279 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 11 holders

UBS Group AG 0.00% Add +1665.5% 112,906 $42K
Geode Capital Management, LLC 0.00% Add +357.9% 110,129 $41K
HRT Financial LP 0.00% New 15,187 $5K
Two Sigma Securities, LLC 0.00% New 12,551 $5K
SBI Securities Co., Ltd. 0.00% Add +1068.6% 2,571 $953
Tower Research Capital LLC (TRC) 0.00% Reduce -36.0% 2,311 $856
Wells Fargo & Company 0.00% New 200 $74
Leonteq Securities AG 0.00% No change 188 $70
International Assets Investment Management, LLC 0.00% No change 45 $18
BlackRock, Inc. 0.00% No change 4 $1
Royal Bank of Canada 0.00% No change 702 $0

"% of holder's portfolio" is JAGX's weight in each manager's 13F, not the share of Jaguar Health Inc. the manager owns.